Dr. Oh on the Role of Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer

Описание к видео Dr. Oh on the Role of Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer

William K. Oh, chief, Division of Hematology and Medical Oncology, professor of Medicine and Urology, discusses the role of docetaxel in the treatment of patients with metastatic hormone-sensitive prostate cancer.

Комментарии

Информация по комментариям в разработке